4.4 Article

Assessment of Selection Bias in Clinic-Based Populations of Childhood Cancer Survivors: A Report From the Childhood Cancer Survivor Study

期刊

PEDIATRIC BLOOD & CANCER
卷 52, 期 3, 页码 379-386

出版社

WILEY
DOI: 10.1002/pbc.21829

关键词

epidemiology; late effects; long-term survival; outcomes research; pediatric oncology

资金

  1. National Cancer Institute [CA 55727]
  2. American Lebanese Syrian Associated Charities (ALSAC)

向作者/读者索取更多资源

Background. It is not known to what extent prevalence estimates of late effects among childhood cancer survivors derived from clinic based samples represent file actual estimates that would he derived if the entire Population of childhood cancer survivors was recruited and evaluated for I particular Outcome. Procedure. In a large retrospective cohort study of childhood cancer survivors, the Childhood Cancer Survivor Study (CCSS), the prevalence of chronic health conditions among participants who reported being seen in a cancer center or long-term follow-up clinic was compared to the prevalence of chronic conditions in the entire cohort. Results. When compared 10 Survivors who had no medical care in the previous 2 years, Survivors accessing medical follow-Lip wore significantly more likely to have chronic health conditions. Relative risks of reporting a chronic health condition were 1.4 (95% CI: 1.3-1.5) if seen in a cancer center or long-term follow-up clinic and 1.2 (959% CI: 1.1-13) if seen in I general meclical care setting. Estimates derived from only those childhood cancer Survivors who were seen in a cancer center or long-term follow-up clinic overestimate the prevalence of any chronic disease by 9.3% (95% CI: 7.0-11.6). Conclusions. Applying chronic condition prevalence estimates from a clinical population to the general population of childhood cancer Survivors must be undertaken with caution. survivorship research must maintain a high level of scientific rigor to ensure that result,; reported in the literature are interpreted within the appropriate context. Pediatr Blood Cancer 2009;52:379-386. (C) 2008 Wiley-Liss, Inc.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.4
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据